换一批
换一批Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high-risk prostate cancer who underwent robot-assisted radical prostatectomy.
作者：
主题词
人类(Humans);男(雄)性(Male);雌氮芥(Estramustine);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);老年人(Aged);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤辅助疗法(Neoadjuvant Therapy);前瞻性研究(Prospective Studies);寡肽类(Oligopeptides);前列腺特异抗原(Prostate-Specific Antigen);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);无病生存(Disease-Free Survival)
DOI
10.1111/iju.15579
PMID
39253858
发布时间
2024-12-05
- 浏览0
International journal of urology
1400-1407页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
